Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alacris Theranostics

Alacris Theranostics
2011 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Corporate LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of cancer treatment strategies. The company offers its therapy guidance to cancer clinics and intends to make technology directly available to patients in the future.

Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Fabeckstrasse 60-62
  • 14195 Berlin
  • Germany

+49 030 00000000

Alacris Theranostics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alacris Theranostics‘s full profile, request access.

Request full access to PitchBook

Alacris Theranostics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Alacris Theranostics‘s full profile, request access.

Request full access to PitchBook

Alacris Theranostics Executive Team (3)

Name Title Board
Seat
Contact
Info
B. Lange Chief Executive Officer
Tatiana Borodina Head of Sequencing Unit
Alexander Kuhn Associate